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CARD9 negatively regulates NLRP3-induced IL-1b
production on Salmonella infection of macrophages
Milton Pereira1, Panagiotis Tourlomousis1, John Wright1, Tom P. Monie2 & Clare E. Bryant1
Interleukin-1b (IL-1b) is a proinﬂammatory cytokine required for host control of bacterial
infections, and its production must be tightly regulated to prevent excessive inﬂammation.
Here we show that caspase recruitment domain-containing protein 9 (CARD9), a protein
associated with induction of proinﬂammatory cytokines by fungi, has a negative role on IL-1b
production during bacterial infection. Speciﬁcally, in response to activation of the nucleotide
oligomerization domain receptor pyrin-domain containing protein 3 (NLRP3) by Salmonella
infection, CARD9 negatively regulates IL-1b by ﬁne-tuning pro-IL-1b expression, spleen
tyrosine kinase (SYK)-mediated NLRP3 activation and repressing inﬂammasome-associated
caspase-8 activity. CARD9 is suppressed during Salmonella enterica serovar Typhimurium
infection, facilitating increased IL-1b production. CARD9 is, therefore, a central signalling hub
that coordinates a pathogen-speciﬁc host inﬂammatory response.
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I
nterleukin-1b (IL-1b) is a cytokine of critical importance in
inﬂammatory, infectious and autoimmune diseases. Its
powerful proinﬂammatory effects mean that production of
this cytokine must be tightly regulated to prevent excessive
inﬂammation. Pro-IL-1b is cleaved to bioactive IL-1b by several
enzymatic complexes, the most important of which are the
inﬂammasomes. Inﬂammasomes assemble in the cytoplasm of
cells and utilize caspases, such as caspase-1 and caspase-8, for
cytokine processing1. Canonical inﬂammasomes comprise a
nucleotide oligomerization domain receptor (NLR), an adaptor
protein (ASC; apoptosis-associated speck-like protein containing
a CARD (caspase recruitment domain)) and effector caspases.
Non-canonical inﬂammasomes are formed in response to
activation of other pattern recognition receptors (PRRs),
such as the complex formed by dectin-1, spleen tyrosine kinase
(SYK) and caspase-8 in response to fungal infection2–4.
Formation of the macromolecular inﬂammasome structure
requires protein–protein interactions, often between CARD
domain-containing proteins, for example, between ASC and
caspase-1, NLR family CARD domain-containing protein 4
(NLRC4) and ASC or NLRC4 and caspase-1. Canonical
inﬂammasomes can recruit multiple NLRs and caspases to the
same inﬂammasome complex to tailor a pathogen-speciﬁc
inﬂammatory response5. This recruitment occurs through
multiple domain-speciﬁc protein interactions, including those
mediated by CARDs. Identifying the ﬁnal composition of
inﬂammasomes formed in response to speciﬁc pathogens or
cellular insults, and how this affects inﬂammasome activity, is
likely to be of major clinical importance in infectious and
inﬂammatory disease research.
CARD9 is a CARD-containing adaptor protein with roles in
activating innate immune signalling, particularly in response to
fungal6 and viral infections7,8. CARD9 regulates dectin-1
stimulation of nuclear factor-kB (NF-kB) activation9, reactive
oxygen species production10 and non-canonical inﬂammasome
assembly3,4, as well as activation of p38 and Jnk during
nucleotide-binding oligomerization domain-containing protein
2 (NOD2) signalling11. Mutations in CARD9 are associated with
chronic inﬂammatory diseases in humans, including those
associated with bacterial rather than fungal infection, such as
Crohn’s disease and colitis12–16. Little is known about whether
CARD9 is important in regulating the host response to bacterial
infection. CARD9 upregulates IL-1b production in fungal
infections, but whether there is a direct link between this
protein and canonical inﬂammasome activity is unclear.
Infection with Salmonella enterica serovar Typhimurium
(S. Typhimurium) triggers the formation of a complex
inﬂammasome that can include NLRC4, NLR family PYRIN
domain-containing protein 3 (NLRP3), ASC, caspase-1 and
caspase-8 (refs 5,17–19). Caspase-1 drives IL-18 and IL-1b
maturation and gasdermin D processing, which leads to
pyroptosis20,21. Caspase-8 is important for IL-1b maturation
but has no clear role in pyroptosis17. The complex composition
of the Salmonella-induced inﬂammasome led us to speculate
whether other CARD domain-containing proteins, such as
CARD9, may regulate its activity. CARD9 regulates SYK
activity and this kinase phosphorylates the CARD domain of
ASC when NLRP3, but not NLRC4, is activated to increase IL-1b
and IL-18 production22–25. We investigated whether CARD9
could regulate canonical inﬂammasome activation in response to
S. Typhimurium infection. Surprisingly, we show that in
response to Salmonella infection CARD9 negatively regulates
NLRP3-induced IL-1b production, but not pyroptosis, in murine
bone marrow-derived macrophages (BMDMs) by two distinct
mechanisms: (i) by ﬁne-tuning pro-IL-1b expression; and (ii) by
reducing NLRP3 activation through modulation of SYK and
caspase-8 activity. Importantly, we show that CARD9 can
negatively regulate canonical NLRP3 inﬂammasome activity and
NOD2-mediated pro-IL-1b synthesis. Our data identify a
negative regulatory role for CARD9 on IL-1b production in
bacterial infection that contrasts its role in fungal infections
in which it drives proinﬂammatory responses. We propose that
CARD9 is a central signalling hub that can negatively or
positively regulate proinﬂammatory signalling to coordinate a
pathogen-speciﬁc host inﬂammatory response to infection.
Results
CARD9 negatively regulates IL-1b from inﬂammasomes. To
evaluate whether CARD9 plays a role in inﬂammasome activity,
we infected BMDMs from wild type (WT), Card9 / and
Nlrc4 / C57BL/6 mice with S. Typhimurium SL1344. As
expected26, Nlrc4 / BMDMs had reduced IL-1b processing
and induction of cell death at all multiplicities of infection
(m.o.i.’s) at early time points, consistent with impaired
inﬂammasome assembly (Fig. 1a,b,d,e,g,h). Card9 / BMDMs,
however, showed a slight reduction in S. Typhimurium-induced
cell death. Decreased pyroptosis is usually coupled to reduced
IL-1b secretion1, but here we observed the opposite effect in
Card9 / BMDMs. At all time points and m.o.i.’s studied, there
was an increase in IL-1b in the supernatant from Card9 /
BMDMs of up to four times that seen from WT cells (Fig. 1a,d,g).
The increased cytokine production could not be explained by
increased intracellular bacterial load, as both WT and Card9 /
BMDMs had comparable intracellular counts (Supplementary
Fig. 1a–c). We measured tumour-necrosis factor-a (TNF-a)
production from the same cell supernatant and showed
that although there is an increase in the production
of this cytokine the amount produced is proportional to the
increase in cell viability, whereas the production of IL-1b is
disproportionally enhanced from the infected Card9 / cells
(Fig. 1a,c,d,f,g,i). BMDM infection with Escherichia coli also
showed increased IL-1b production in Card9 / in comparison
with WT macrophages without affecting pyroptosis, intracellular
bacteria counts and TNF-a production (Fig. 1j–o and
Supplementary Fig. 1d–e). It is possible that the effects of
CARD9 on Salmonella-induced inﬂammasome activity may be
indirect, for example, by regulating the autocrine production of
cytokines such as IL-10, which is reduced in CARD9-deﬁcient
neutrophils infected with Mycobacterium tuberculosis27. An
IL-10-mediated effect of CARD9 on Salmonella-induced IL-1b
production from macrophages is unlikely, however, as elevated
IL-1b production occurs within 2 h of infection, whereas IL-10
production occurs later in infection28.The increased IL-1b
production in vitro is also seen in the production of this
cytokine from a sub-lethal in vivo model of systemic infection
with S. Typhimurium. WT and Card9 / mice infected with
S. Typhimurium (strain M525P) had similar bacterial burdens in
the spleen at days 1, 3 and 7 post infection (Supplementary
Fig. 1f–g). Immunoblotting of cell lysates from isolated spleen
cells revealed an upregulation of pro-IL-1b in Card9 / mice at
day 7, without an increase in the caspase-1 p10 subunit
(Fig. 1p,q). The mature cytokine could not be reliably measured
in mouse sera at this time point, consistent with other published
data26.
One explanation for these data could be the well-known role of
CARD9, during fungal infection, in regulating NF-kB signalling
pathways6 such that enhanced expression of pro-IL-1b could
result in an overall increase in IL-1b production without effecting
inﬂammasome-induced cytokine processing and pyroptosis.
BMDMs were infected with S. Typhimurium at an m.o.i. 5 for
2 h and, following mRNA extraction, we performed quantitative
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Figure 1 | CARD9 negatively regulates IL-1b production in vitro and in vivo. (a,d,g) IL-1b secretion (as measured by ELISA), (b,e,h) cellular viability
(as measured by LDH release) and (c,f,i) TNF-a (as measured by ELISA) of WT, Nlrc4 / and Card9 / BMDMs after infection with S. Typhimurium
SL1344 at m.o.i.’s 1, 10 and 50 for 2 (a–c), 6 (d–f) and 24 (g–i) h. (j,m) IL-1b secretion, (k,n) cellular viability and (l,o) TNF-a after infection of WT and
Card9 / BMDMs with E. coli P19A at m.o.i.’s 1, 10 and 50 for 2 (j–l) and 6 (m–o) h. (p) Immunoblot analysis of pro-IL-1b, caspase-1 and b-actin in spleen
cells isolated from infected WT and Card9 / C57BL/6 mice after intravenous infection with S. Typhimurium M525P (4 103 colony-forming units).
(q) Densitometric analysis of this immunoblot. *Po0.05 (one-way analysis of variance with Tukey’s multiple comparisons test). (a–i) Data from ﬁve
independent experiments (mean and s.e.m.). (j–o,q) Data from two independent experiments (mean and s.e.m). (p) Representative data from two
independent experiments, using cells pooled from four to six mice per genotype, plus two negative controls per genotype. Mice were from 8 to 16 weeks
old, both male and female.
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PCR analysis for genes involved in inﬂammasome signalling,
NF-kB target genes and other genes coding for proteins known to
associate with CARD9. Most NF-kB target genes, such as TNF-a
and RANTES, were similarly upregulated in WT and Card9 /
BMDMs (Fig. 2c,d). Levels of pro-IL-1b, however, whilst
signiﬁcantly upregulated in WT cells (around 800-fold increase)
were even more enhanced in Card9 / cells (1,200 fold-
increase, Po0.01; Fig. 2a). This pattern of enhanced pro-IL-1b
was also observed at the protein level (Fig. 2g). NLRP3 was
upregulated to a similar level in both WT and Card9 /
BMDMs (Fig. 2b). SYK and caspase-8, proteins know to be
involved in non-canonical inﬂammasome activity and NLRP3
activation18,24, were also found to be slightly upregulated after
infection of Card9 / BMDMs at both the mRNA and protein
level (Fig. 2e–i). Several other genes (Naip5, Nlrc4, Pycard,Casp1,
Fadd, Bcl10, Malt1 and Il18) showed no difference in expression
between WT and Card9 / -infected BMDMs (Supplementary
Fig. 2a–h). None of the analysed transcripts or proteins showed
basal differences between uninfected WT and Card9 / cells
(Supplementary Fig. 2i–j).
To determine whether CARD9 affects inﬂammasome
activation, as well as pro-IL-1b expression we analysed, by
immunoblotting, the BMDM supernatants for pro-IL-1b and
caspase-1 processing. Our data show increased IL-1b protein
expression in Card9 / BMDMs at 2 and 6 h post infection
compared with WT cells. As expected BMDMs from ASC
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Figure 2 | CARD9 modulates pro-IL-1b expression. (a–f) Quantitative PCR analysis of WTand Card9 / BMDMs infected with S. Typhimurium (m.o.i. 5)
for 2 h, compared with uninfected controls. (a) Pro-IL-1b, (b) NLRP3, (c) TNF-a, (d) RANTES, (e) caspase-8 and (f) SYK. (g) Expression of pro-IL-1b, SYK,
pro-caspase-8, pro-caspase-1, CARD9, ASC, b-actin in cell lysates, and caspase-1 p10, caspase-8 p18 and IL-1b in culture supernatants from WT, Card9 /
 and Pycard / BMDMs after 2 or 6 h of infection with S. Typhimurium (m.o.i. 5) and relative densitometry (Card9 //WT) in culture supernatants
(h) or cell lysates (Card9 //WT, actin-normalized) (i). *Po0.05 in comparison with uninfected control, unless stated in the graph (one-way analysis of
variance with Tukey’s multiple comparisons test). (a–f,h,i) Data from three independent experiments (mean and s.e.m.). (g) Image is representative of
three independent experiments.
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knockout mice (Pycard / ) were impaired in the production of
IL-1b and the mature forms of both caspase-1 and caspase-8.
Caspase-1 processing was similar in both WT and Card9 /
BMDMs at 2 and 6 h, suggesting that the increased IL-1b
production in Card9 / cells is not due to an increase in
caspase-1 activation. We recently showed that caspase-8 plays an
important role in canonical inﬂammasome processing of IL-1b in
response to S. Typhimurium, but not pyroptosis, which is wholly
dependent on caspase-1 (ref. 17) via cleavage and activation of
Gasdermin D20,21. The mature form of caspase-8 was increased in
Card9 / BMDMs at 2 h (Fig. 2g,h) suggesting that, in the
absence of CARD9, increased caspase-8 activity is responsible for
the increased conversion of pro-IL-1b to its mature form.
CARD9 functions independently of NLRC4 and AIM2.
S. Typhimurium stimulates IL-1b production via both NLRC4
and NLRP3 activation26. To assess whether CARD9 affects
IL-1b production by each of these NLRs LPS-primed WT,
Nlrc4 / , Nlrp3 / and Card9 / BMDMs were transfected
with ultrapure ﬂagellin from Salmonella for 1 h, followed by
quantiﬁcation of IL-1b production. IL-1b was elevated to similar
levels in WT, NLRP3 and CARD9 knockout macrophages,
but, as expected, was below the detection limit
for Nlrc4 / BMDMs (Fig. 3a). CARD9 modulation of inﬂa-
‘mmasome-induced IL-1b production therefore occurs inde-
pendently of NLRC4.
To conﬁrm this observation, we infected WT BMDM with
either WT S. Typhimurium or a mutant strain deﬁcient in
NLRC4 activation5 (DﬂiCDﬂjBDprgJ). Both WT and Card9 /
BMDM infected with the DﬂiCDﬂjBDprgJ strain had impaired
levels of pyroptosis in comparison with cells infected with WT
bacteria (Fig. 3b–d). IL-1b secretion was elevated in BMDMs
infected with WT S. Typhimurium, but markedly reduced, as
expected, in BMDMs after infection with the DﬂiCDﬂjBDprgJ
mutant. In Card9 / BMDMs, however, IL-1b production was
increased after infecting cells with both strains of bacteria
(Fig. 3e–g). At 2 h post infection Card9 / BMDMs produced
detectable IL-1b after infection with both bacterial strains
although the level was much reduced in cells infected with
the DﬂiCDﬂjBDprgJ mutant. No IL-1b was detected in WT cells
at this time point infected with the DﬂiCDﬂjBDprgJ strain.
Card9 / macrophages secreted 2.5 times more IL-1b than WT
BMDMs at both 6 and 24 h post infection, time points known to
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Figure 3 | CARD9 does not control IL-1b produced via NLRC4. (a) IL-1b production from LPS-primed BMDMs after transfection with ultrapure ﬂagellin.
(b–d) Cellular viability and (e–g) IL-1b production from unprimed BMDMs after infection with S. Typhimurium WTor DﬂiCDﬂjBDprgJ (deﬁcient in NLRC4
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involve NLRP3 activity in response to Salmonella infection5. This
is consistent with our ﬂagellin data suggesting that IL-1b
produced via NLRC4 occurs independently of CARD9.
To determine whether AIM2 inﬂammasome activity could be
regulated by CARD9, LPS-primed WT and Card9 / BMDMs
were stimulated with the AIM2 ligand poly(dA:dT), but no
differences in cellular viability or IL-1b secretion were seen
(Supplementary Fig. 3).
CARD9 negatively regulates IL-1b production through NLRP3.
To determine whether the NLRC4-independent impact of
CARD9 on IL-1b production resulted from activation of NLRP3
we infected BMDMs with S. Typhimurium at an m.o.i. 10 in
the presence or absence of either glibenclamide or MCC950
(refs 29,30). At 2 and 6 h post infection, both WT and Card9 /
BMDMs showed similar levels of cellular viability in the presence
or absence of glibenclamide (Fig. 4a,b), while MCC950
slightly inhibited cell death in Card9 / BMDM (Fig. 4e,f).
Glibenclamide and MCC950 did not affect IL-1b production
in WT cells, but they did reduce the enhancement of IL-1b
production in Card9 / BMDMs to a level comparable to that
seen in WT cells. These data suggest that the increased IL-1b
production from Card9 / macrophages after Salmonella
infection is driven by enhanced NLRP3 activation (Fig. 4c,d,g,h).
To verify whether CARD9 regulates IL-1b production via
NLRP3, LPS-primed (200 ngml 1 for 3 h) WT, Nlrc4 / ,
Nlrp3 / and Card9 / BMDMs were stimulated for 1 h with
the NLRP3 activator nigericin (10 mM, 1 h). Nigericin, as
expected, stimulated cell death and IL-1b secretion in WT
and Nlrc4 / , but not in Nlrp3 / , BMDMs (Fig. 4i,j). Levels
of IL-1b produced by Card9 / BMDMs were greatly enhanced
in comparison with WT cells after stimulation with nigericin.
Similar levels of cellular viability were seen in nigericin-
stimulated WT and Card9 / BMDMs (Fig. 4i,j). Similarly,
incubation of WT, Card9 / and Nlrp3 / BMDMs with ATP
showed no alterations in cellular viability (Fig. 4k) and a
signiﬁcant increase in IL-1b production in Card9 / cells in
comparison with WT cells, while Nlrp3 / BMDMs showed
great impairment in IL-1b production (Fig. 4l). These data
conﬁrm that the effects of CARD9 on inﬂammasome function are
speciﬁc for NLRP3-mediated IL-1b production and are
uncoupled from inﬂammasome-driven pyroptosis.
CARD9 inhibits NLRP3 activation upstream of speck formation.
The enhanced production of NLRP3-dependent IL-1b secretion in
Card9 / BMDMs is independent of caspase-1 (Fig. 2g–i). How
then does the presence of CARD9 inhibit processing of IL-1b?
We investigated ﬁrst whether CARD9 acts upstream or
downstream of the canonical inﬂammasome adaptor protein ASC.
WT, Card9 / and Pycard / LPS-primed BMDMs were
stimulated with nigericin (5mM for 30min), ﬁxed and stained for
ASC and CARD9. Both WT and Card9 / cells formed ASC
specks (Fig. 5a). Immunolocalization of endogenous CARD9
suggests that this protein forms aggregates in stimulated and
unstimulated WT and Pycard / BMDMs, but it does not
co-localize with ASC specks suggesting that CARD9 is not
recruited to the ASC speck (Fig. 5a). Card9 / BMDMs
show some non-speciﬁc background staining, but it is much
fainter than the CARD9 immunolocalization in WT and
Pycard / cells.
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To determine whether CARD9 associates with ASC before
speck formation co-immunoprecipitation analysis of WT BMDM
lysate was performed using anti-ASC, anti-CARD9 or anti-SYK
antibodies as bait. SYK was targeted because of its involvement in
both CARD9 and ASC signalling22,24. Co-immunoprecipitations
conﬁrmed that both ASC and CARD9 interact with SYK in
unstimulated or uninfected WT BMDMs. ASC and CARD9
do not, however, directly interact with one another (Fig. 5b).
After Salmonella infection or nigericin treatment, ASC
immunoprecipitated preferentially with the phosphorylated
form of SYK (p-SYK) conﬁrming previously published data25,
while CARD9 predominantly interacted with unphosphorylated
SYK (Fig. 5b). Phosphorylated SYK regulates NLRP3
activation22–25, so the interaction of CARD9 with unpho-
sphorylated SYK may prevent its subsequent phosphorylation
thereby inhibiting NLRP3 activation. No proteins were
pulled down in Card9 / and Pycard / isotype controls
IPs (Supplementary Fig. 4). Consistent with this hypothesis we
found increased phosphorylation of SYK in unstimulated,
infected or nigericin-treated BMDM from Card9 / mice in
comparison with WT cells (Fig. 5c). This supports the idea that in
the absence of CARD9 there is increased SYK phosphorylation,
which facilitates NLRP3 activation.
CARD9 inhibits NLRP3 activation through SYK and caspase-8.
Our immunoblotting (Fig. 2g), co-immunoprecipitation (Fig. 5b)
and SYK phosphorylation data (Fig. 5c) all suggest that
CARD9 regulates NLRP3 activation by a SYK and caspase-8-
dependent mechanism. To investigate this hypothesis
LPS-primed BMDMs were infected in the presence or absence of
R406, a speciﬁc SYK inhibitor, and Z-IETD-FMK, a caspase-8
inhibitor. The expression of pro-IL-1b, caspase-8, caspase-1,
SYK and CARD9 are similar in LPS-primed WT and Card9 /
BMDM in the presence or absence of these inhibitors
(Supplementary Fig. 5). BMDM infection with S. Typhimurium
(m.o.i. 10) in the presence of the caspase-8 inhibitor
Z-IETD-FMK, as expected, had no effect on cell viability as
measured by lactate dehydrogenase (LDH) activity (Fig. 6a)
because caspase-8 does not induce pyroptosis in response to
infection with this pathogen17. It is possible, however,
that caspase-8 may induce cell death in response to infection by
other mechanisms31. IL-1b production was reduced in both WT
and Card9 / macrophages in the presence of Z-IETD-FMK,
which is consistent with our data suggesting that caspase-8 plays
an important role in IL-1b processing during Salmonella
infection17. Importantly IL-1b secretion in infected Card9 /
macrophages, in the presence of Z-IETD-FMK, was now no
different to that of infected WT BMDM (Fig. 6b) supporting
the hypothesis that the increased IL-1b production observed
in Card9 / cells is indeed mediated by caspase-8.
Treatment with Z-IETD-FMK also reduced IL-1b secretion
from nigericin-stimulated Card9 / BMDMs to the same level
as WT cells (Fig. 6c,d).
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Cell viability in BMDMs infected with S. Typhimurium in the
presence of the SYK inhibitor R406 was unaffected, as
expected, given that SYK activity does not regulate NLRC4
activity (Fig. 6e)24. SYK inhibition decreased the amount
of IL-1b secreted by infected Card9 / BMDMs to similar
levels to those seen in WT cells (Fig. 6f). SYK inhibition, however,
had less effect on IL-1b production than caspase-8 inhibition
probably because caspase-8 is activated by both NLRC4
and NLRP3 in response to Salmonella infection17, whereas SYK
only regulates NLRP3 activation24. Stimulation of LPS-primed
WT or Card9 / BMDMs with nigericin in the presence
of R406 elicited similar levels of IL-1b production from
both cell types (Fig. 6h). SYK inhibition led to a small, but
statistically signiﬁcant, increase in cell viability in both WT
and CARD9 knockout BMDM stimulated with nigericin probably
due to its effect on NLRP3-induced caspase-1 activation25
(Fig. 6g).
SYK regulates NLRP3 activity in BMDM, but it does not affect
NLRP3 activation in bone marrow-derived dendritic cells
(BMDCs)24. If CARD9 plays a speciﬁc role in regulating
NLRP3 activity through SYK then there should be no difference
in NLRP3-stimulated IL-1b production between WT and
Card9 / BMDC. Stimulation of LPS-primed BMDCs with
nigericin (5 mM, 1 h) induced similar levels of IL-1b processing
and cell death in both Card9 / and WT BMDCs (Fig. 6i,j).
Similarly, no increase in IL-1b processing was observed in
unprimed Card9 / compared with WT BMDCs infected with
S. Typhimurium (m.o.i. 10) (Supplementary Fig. 6). Taken
together, these data support a role for CARD9 in regulating SYK
activation of NLRP3 to control caspase-8 processing of IL-1b in
the canonical inﬂammasome in BMDMs.
SYK controls caspase-8 recruitment to the inﬂammasome. How
does SYK regulate caspase-8 activity in response to NLRP3
activation? We hypothesized that SYK alters caspase-8 recruit-
ment to the inﬂammasome speck. To test this hypothesis we
stimulated LPS-primed WT, Card9 / and Pycard /
BMDMs with nigericin in the presence or absence of R406, and
stained the cells for active caspase-8 and caspase-1. After
ﬁxation and counterstaining with 4,6-diamidino-2-phenylindole,
we observed speck-like structures for both caspase-1 and
caspase-8 in WT and CARD9 knockout macrophages, but not in
Pycard /BMDM (Fig. 7a). Quantiﬁcation of the number of
cells containing specks (1,000 cells per treatment, selected from
random ﬁelds) conﬁrmed that Card9 / BMDMs had more
caspase-8-positive specks than WT cells. The number of WT and
Card9 / BMDM containing caspase-1-positive specks was very
similar to each other (Fig. 7c). In the presence of the SYK
inhibitor R406 the number of cells containing caspase-8-positive
specks was reduced compared with cells without inhibitor, but
was the same for WT and Card9 / BMDM (Fig. 7b). These
observations corroborate the caspase-8 cleavage data (Fig. 2g) and
caspase-8 inhibition assays (Fig. 6a–h) supporting the concept
that SYK and CARD9 regulate the recruitment of caspase-8 to the
inﬂammasome after NLRP3 activation to process IL-1b.
CARD9 is a central signalling hub for inﬂammatory signalling.
Our data identify a novel, inhibitory, role for CARD9 in the
regulation of NLRP3-induced IL-1b production. CARD9
regulates inﬂammatory responses downstream of numerous PRRs
including NOD2, Dectin-1 and RIG-I. This suggests that CARD9
may function as a signalling hub coordinating the cellular
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response to infection and permitting a rapid integrated
inﬂammatory response to a range of PRRs. To test this hypothesis
we investigated whether Salmonella infection alters CARD9
protein expression and thereby potentially alters the resulting
level of inﬂammasome activation. CARD9 is constitutively
expressed in many cell types including macrophages11 and after
infection of WT BMDM with S. Typhimurium (m.o.i. 10) a
progressive decrease in the expression of this protein was
observed within 30min after infection (Fig. 8a). The decrease in
CARD9 expression was independent of inﬂammasome assembly,
as similar CARD9 expression proﬁles were seen in infected
LPS-primed or unprimed Pycard / BMDMs (Fig. 8b).
Nigericin stimulation does not trigger CARD9 downregulation
(Fig. 8c) supporting our hypothesis that the regulation of
CARD9 expression in macrophages is speciﬁcally
downregulated on Salmonella infection possibly to maximize
the host inﬂammasome response to infection.
Our data and other published work supports a role for CARD9
as an important regulator of PRR signalling where it can up- or
downregulate pro-inﬂammatory cytokine production in a
pathogen-dependent manner6,8,32. If CARD9 is a central
regulator of the inﬂammatory response to pathogens then
signalling through other CARD9-dependent PRRs that
recognize salmonellae should also be altered in response to
infection. NOD2 recruits CARD9 to activate p38 and JNK MAPK
signalling11,33, but NF-kB signalling is activated independently of
this adaptor protein. Pro-IL-1b expression is transcriptionally
regulated by NF-kB, p38 and JNK MAPK, whereas TNF-a
transcription is independent of p38 and JNK activity34.
We investigated whether CARD9 was important in regulating
NOD2-induced signalling in response to S. Typhimurium
infection. WT and Nod2 / BMDMs were infected with
S. Typhimurium (m.o.i. of 10), and the levels of IL-1b and
TNF-a were determined by ELISA. Infection of Nod2 /
macrophages induced a small increase in IL-1b production, but
suppressed TNF-a production (Supplementary Fig. 7a–c). These
data are consistent with the NOD2-CARD9 axis negatively
regulating pro-IL-1b production through an action on
MAPK signalling independently of NOD2 induction of
TNF-a. Consistent with this idea, overstimulation of NOD2 at
the same time as infection with S. Typhimurium leads to a
CARD9- and NOD2-dependent decrease in pro-IL-1b expression
(Supplementary Fig. 7d). Functional association network analysis
showed that the primary interactome of CARD9 consists of key
immune and death signalling pathways in both mice and humans
(Supplementary Fig. 8). Collectively these data support the idea
that CARD9 functions as a signalling hub to co-ordinate
inﬂammatory responses to pathogens such as Salmonella.
Discussion
In this study we have identiﬁed a new role for CARD9 as a
negative regulator of IL-1b production in response to bacterial
infection. This is in stark contrast to the role of CARD9 in fungal
signalling where this adaptor is important for driving
pro-inﬂammatory signalling responses to infection3,6. The
recognition of infection by host cells triggers a series of
complex, pathogen-speciﬁc, signalling events to drive an
appropriate inﬂammatory response. It is increasingly clear that
inﬂammatory signalling pathways do not function in isolation,
but form complex networks in which key constituents act as
nodes or hubs linking apparently distinct pathways. The data we
present here, along with that of other published studies,
clearly indicate that CARD9 is one such protein. CARD9
coordinates Toll-like receptor-dependent and independent
NF-kB signalling6,9,11,35, reactive oxygen species production10,
autophagy36, non-canonical inﬂammasome function3 and, as we
now demonstrate, canonical inﬂammasome assembly in a
context-dependent manner. Importantly, the speciﬁc role of
CARD9 differs between cell types, thereby contributing a further
level of regulatory control in enabling cell speciﬁcity in the host
response to infection 32,35,37.
Our data show CARD9 ﬁne-tunes IL-1b production in two
distinct ways (Supplementary Fig. 9). During ‘signal 1’, CARD9
speciﬁcally downregulates pro-IL-1b transcription without
affecting other NF-kB target genes. This occurs following
activation of p38 and JNK signalling via NOD2, and is consistent
with reports that NOD2 can have speciﬁc inhibitory roles that are
dependent on the context of its activation38–43. How CARD9
regulates pro-IL-1b in this context remains to be fully elucidated,
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but is likely to involve the transcription factor AP-1. AP-1 is a
known transcriptional regulator of pro-IL-1b (ref. 44), which is
itself regulated by p38 and JNK activity45. There is, therefore,
increased expression of pro-IL-1b during the ‘signal 1’ phase of
inﬂammasome stimulation in Card9 / cells. However, in WT
and Card9 / LPS-primed macrophages, which express similar
levels of pro-IL-1b, the production of IL-1b is further increased in
Card9 / compared with WT cells. This suggests the elevated
production of IL-1b from Card9 / cells is not solely due to the
increased pro-IL-1b substrate availability, but is also due to an
effect of CARD9 during ‘signal 2’ of inﬂammasome activation.
During ‘signal 2’, CARD9 suppresses SYK phosphorylation,
which consequently reduces ASC phosphorylation and the
subsequent assembly and activation of the inﬂammasome. In
macrophages, p-SYK phosphorylates ASC, enhancing NLRP3
inﬂammasome activity24,25, whereas in dendritic cells SYK has no
effect on the canonical NLRP3 inﬂammasome24. Consistent with
these studies our data clearly show that CARD9 negatively
regulates the activity of NLRP3 in macrophages, but not
in dendritic cells. Our data suggest that, in addition to the
well-described regulatory role for CARD9 downstream of SYK, it
is also possible that CARD9 can act upstream of SYK during
bacterial infection. The regulation of SYK phosphorylation
by CARD9 speciﬁcally alters caspase-8 recruitment to the
inﬂammasome explaining why we see changes in IL-1b
production independently of any effect on pyroptosis. In
Salmonella infection caspase-8 processes IL-1b but does not
affect pyroptosis17. Precisely how ASC phosphorylation enhances
caspase-8 recruitment is unclear, but as SYK phosphorylates
ASC on its CARD domain24 it is plausible that altering the
pattern of ASC phosphorylation could impair the CARD/CARD
interaction between ASC and caspase-1 (ref. 46) and favour
interactions between the ASC PYD and Caspase-8 DED47.
Identiﬁcation of negative regulators of inﬂammasome
activation may have important clinical implications because
dysregulated inﬂammasome activity is associated with a number
of important diseases2,48. Genome-wide association studies found
strong correlations between loss-of-function CARD9 mutations
and an increased likelihood of developing inﬂammatory
diseases12–16. In a M. tuberculosis infection model CARD9
knockout mice have an increased bacterial burden and
develop exacerbated systemic inﬂammatory responses27, further
strengthening the link between CARD9 and inﬂammatory
diseases. Similarly, Card9 / mice are deﬁcient in controlling
Candida albicans infection, a fungal pathogen capable of
stimulating NLRP3 (ref. 6). These in vivo and clinical
observations emphasize CARD9 role as a negative regulator for
inﬂammation, possibly by ﬁne-tuning NLRP3-mediated IL-1b
production. In conclusion we have identiﬁed a novel negative
regulatory role for CARD9 on IL-1b production in macrophages
by modulating pro-IL-1b expression and caspase-8 recruitment to
the inﬂammasome in response to bacterial infection. These
data support a role for CARD9 as a central signalling hub in co-
ordinating innate immune inﬂammatory responses to infection.
Methods
Mice. WT C57BL/6 mice were obtained from Charles River, UK. Nlrc4 / ,
Nlrp3 / and Pycard / mice on a C57BL/6 background were produced by
Millenium Pharmaceuticals and obtained from Kate Fitzgerald (University of
Masschusetts). Card9 / mice on a C57BL/6 background, originally produced by
Xin Lin (University of Texas)11, were provided by David Underhill (Cedars-Sinai
Medical Center). Nod2 / mice were provided by Peter Murray (St. Jude
Children’s Research Hospital). Mice were backcrossed on a C57BL/6 background at
least eight generations. All mice strains were bred independently. All work
involving live animals complied with the University of Cambridge Ethics
Committee regulations and was performed under the Home Ofﬁce Project License
number 80/2572.
In vivo infections. S. Typhimurium M525P was grown statically for 18 h at
37 C in LB Broth (Sigma), then washed and resuspended in PBS (Sigma).
1.90–2.04 104 colony-forming units per mouse were administered systemically to
8- to 16-week-old mice, both male and female, via the lateral tail vein, while control
mice were inoculated with PBS only. Mice were killed at days 1, 3 and 7 after
infection and their spleens and livers were aseptically removed. Organs were
homogenized in 10ml sterile water using a Colworth stomacher. Organ
homogenates were then 10-fold serially diluted in PBS, plated on LB agar plates and
incubated overnight at 37 C followed by enumeration of colony-forming units.
To obtain splenocyte cell suspensions, spleens were disrupted through a 70 mm
cell strainer (BD Biosciences), washed in RPMI containing 2% Hyclone,
resuspended in Red Blood Cell lysis buffer (Sigma) and incubated for 10min at
room temperature. The suspension was then centrifuged at 300g for 10min and the
pellet washed twice in RPMI. The puriﬁed splenocytes were lysed and the proteins
probed by immunoblotting as described below.
All mice were housed in a speciﬁc pathogen-free facility and all work involving
live animals complied with the University of Cambridge Ethics Committee
regulations under Home Ofﬁce Project License number 80/2572.
Cell culture and stimulation. Primary BMDMs were prepared and cultured for
6–9 days as previously described17. BMDCs were prepared and cultured for 7–10
days as previously described49. Brieﬂy, mice were killed by cervical dislocation, the
skin was sterilized with ethanol (70%) before removal of the leg. The tibia and
femur were removed, cleaned of muscle and the proximal and distal epiphysis cut
away. For BMDMs, the bone marrow was ﬂushed out using DMEM supplemented
with 10% FCS (Thermo Fisher Scientiﬁc), 20% L929 conditioned media and 5mM
L-glutamine (Sigma). For BMDCs, the bone marrow was ﬂushed out using BMDC
growth media (RPMI 1640 supplemented with 10% FCS, 50 mM 2-mercaptoethanol
and 1,000Uml 1 granulocyte–macrophage colony-stimulating factor (Thermo
Fisher Scientiﬁc). The bone marrow cells were centrifuged (300g for 10min at
15 C) and resuspended in appropriate growth media. Cells were cultured at 37 C
in 5% CO2 and growth media replaced every 2 days. Infection of BMDM with
S. Typhimurium strain SL1344 and DﬂiCDﬂjBDprgJ was performed as previously
described17. For NLRP3 inhibition assay, the cells were pre-incubated with
glibenclamide (Sigma) 200mM, MCC950 10 mM (Cayman Chemical) or
vehicle control (dimethylsulfoxide) for 15min and infection was carried out as
described above. For NOD2 co-stimulation assay, the cells were infected with
S. Typhimurium in the presence or absence of muramyl dipeptide 10 mgml 1
(Invivogen).
Selected experiments required BMDMs primed with LPS. This was performed
by incubating the cells in growth media containing 200 ngml 1 ultrapure LPS
from E. coli O111:B4 (InvivoGen) for 3 h at 37 C and 5% CO2, followed by washes
in media alone. For stimulation experiments, the LPS-primed BMDMs were
incubated with nigericin 10 mM (Sigma), 5mM ATP (Sigma) or 60 ng ultrapure
ﬂagellin from S. Typhimurium (Invivogen), after incubation at room temperature
for 20min with Profect-P1 reagent (Target Systems) for transfection complex
formation. AIM2 stimulation was performed using Poly(dA:dT)/LyoVec
(Invivogen) 2 mgml 1 for 4 h. Caspase-8 inhibition experiments were performed
in LPS-primed cells by the addition of the stimuli with or without 10 mM
Z-IETD-FMK (MBL International). SYK inhibition experiments were conducted
by pre-incubating the LPS-primed cells for 1 h with or without 1 mM R406
(Invivogen), followed by stimulation in presence or absence of 1 mM R406.
Quantitative PCR. Following stimulation, cells were treated with RNAprotect Cell
Reagent (Qiagen) and total RNA was isolated using the RNeasy Mini kit (Qiagen)
according to the manufacturer’s instructions. Genomic DNA was removed using
the TURBO DNA-free kit (ThemoFisher Scientiﬁc). The primers used
(Supplementary Table 1) were selected based on data submitted to the primer bank
database (http://pga.mgh.harvard.edu/primerbank/index.html)50. The quantitative
RT–PCR was performed with the SensiFAST One-Step Real-Time PCR kit
(Bioline) using a Rotor-Gene Q real-time PCR cycler (Qiagen). Data analysis was
carried out using the mean of glyceraldehyde 3-phosphate dehydrogenase and
b-actin as reference genes, using Pfafﬂ method to correct for reaction efﬁciency51.
Immunoprecipitation, protein precipitation and immunoblot. Cell culture
supernatant and spleen homogenate proteins were precipitated using methanol and
chloroform. Brieﬂy, a volume of the sample was vortexed with one volume of
ice-cold methanol and 0.25 volume of chloroform, followed by centrifugation
(4 C, 16,000g, 12min). The intermediate phase was collected, washed two times in
ice-cold methanol and resuspended in Pierce Lane Marker Reducing Sample Buffer
(Life Technologies).
Cells were lysed in lysis buffer containing 10mM Tris (pH 7.4), 150mM
NaCl, 5mM EDTA, 1% Triton X-100, 10mM NaF, 1mM NaVO4, 20mM
phenylmethylsulfonyl ﬂuoride, phosphatase inhibitor cocktail 3 (1 in 100 dilution,
Sigma) and protease inhibitor cocktail (1 in 100 dilution, P8340, Sigma). Protein
levels were quantiﬁed using Pierce BCA Protein Assay Kit (Life Technologies).
The samples were used for co-immunoprecipitation or incubated for 5min at
100 C with Pierce Lane Marker Reducing Sample Buffer (Life Technologies) for
immunoblotting.
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For co-immunoprecipitation analysis cells were reversibly crosslinked with
5mM DTBP (Fisher Scientiﬁc) for 30min at 4 C then lysed as described
above. Protein concentration was adjusted to 600 mgml 1, and 800ml was
incubated overnight with 2 ml antibody (goat anti-ASC (sc-33958, Santa Cruz),
rabbit anti-CARD9 mouse (12283, Cell Signaling) and mouse anti-SYK
(MA1-19332, Thermo Scientiﬁc)) and 20 ml of Protein A/G PLUS-agarose beads
(Santa Cruz). The remainder of the protein sample was stored for immunoblotting.
After incubation, the beads were washed four times in lysis buffer, ressuspended
with Pierce Lane Marker Reducing Sample Buffer (Life Technologies), incubated
for 5min at 100 C, centrifuged for 1min at 5,000g and the supernatant used for
immunoblotting.
Immunoblots were probed using the following primary antibodies: caspase-1
p10 (mouse) (sc-514, Santa Cruz) 1 in 500; cleaved caspase-8 (rabbit) (8592, Cell
Signaling) 1 in 500; caspase-8 (rabbit) (IG12, Enzo) 1 in 500; IL-1b (goat) (AF-401,
R&D Systems) 1 in 1,000; SYK (mouse) (MA1-19332, Thermo Scientiﬁc) 1 in
1,000; p-SYK (rabbit) (2711, Cell Signaling) 1 in 1,000; ASC (rabbit) (AL177, Enzo)
1 in 2,000; B-Actin (mouse) (AB3280, ABCAM) 1 in 2,500; and CARD9, mouse
preferred (rabbit) 1 in 1,000 (12283, Cell Signaling). The secondary antibodies used
were as follows: anti-goat IgG-HRP (sc-2922, Santa Cruz) 1 in 5,000; anti-mouse
IgG-HRP (7076, Cell Signaling) 1 in 6,000; and anti-rabbit IgG-HRP (A24537,
Thermo Scientiﬁc) 1 in 6,000 as appropriate. Uncropped scans of immunoblots are
provided as Supplementary Figs 10–22.
Immunoﬂuorescence microscopy. To label CARD9 and ASC, stimulated cells
were ﬁxed in  20 C methanol for 5min, after washing with PBS, non-speciﬁc
labelling was blocked by incubation at 37 C for 1 h in 10% normal goat serum
(Dako) containing 0.1% saponin (Sigma). ASC was labelled with anti-ASC primary
(1:500 dilution, AL177; Enzo) and Alexa-ﬂuor 568 secondary antibody (1:1,000
dilution, anti-rabbit Alexa-ﬂuor 568 (Invitrogen)). To label CARD9 the cells
were subsequently blocked in PBS containing 1% BSA and 0.1% saponin.
Immuno-labelling was performed with anti-CARD9 (1:300 dilution, sc-49408,
Santa Cruz) and anti-Rabbit-Alexa 430 (1:1,000 dilution, Invitrogen). Cells
were counterstained using 4,6-diamidino-2-phenylindole mounting medium
(Vecta Labs).
Speck enumeration was performed in cells stimulated with nigericin in
presence of FAM-FLICA Caspase 8 Assay Kit, green (1:150, Immunochemistry
Technologies) and FAM-FLICA Caspase 8 Assay Kit, red (1:150, Immuno-
chemistry Technologies), followed by ﬁxation with 4% paraformaldehyde for
15min at room temperature. Non-speciﬁc labelling was prevented by
incubating cells with 10% normal goat serum (Dako) and 0.1% saponin (Sigma) for
1 h. In all, 1,000 cells per treatment were selected from random ﬁelds and the
specks counted.
Cellular viability assays and intracellular bacteria counts. Cytotoxicity was
quantiﬁed by measuring LDH activity after being released from live cells.
Uninfected BMDMs (ranging from 12,500 to 200,000 cells per well) were used as
standards. After treatment, the cells were washed three times with pre-warmed
PBS and the intracellular LDH was released by lysing the cells with Triton
X-100 1.2% for 1 h at 37 C. LDH activity was then measured using CytoTox 96
Non-Radioactive Cytotoxicity Assay (Promega)17. Cellular viability was them
calculated in relation to the uninfected control containing 200,000 cells
(100% viability). Intracellular bacteria counts were performed using LB agar plates
after overnight incubation.
Cytokine quantiﬁcation. Secreted cytokines were measured in the culture
supernatants. All cytokines were measured according to the manufacturer’s
instructions. For IL-1b OptEIA Mouse IL-1b Set (BD Biosciences) was used and
TNF-a using the DuoSet ELISA kit (R&D Systems).
Computational analysis. Functional association network analysis was performed
using STRING v10 (ref. 52) and either murine or human CARD9 as search
proteins. Primary interactomes were initially established using a high-conﬁdence
cutoff score of 0.7 and a maximum of 50 interaction partners. These
interactomes were further expanded by relaxing the inclusion criteria to
a cutoff value of 0.4. Data are presented with the thickness of the line
between protein nodes representing the conﬁdence level associated with that
interaction.
Statistical analysis. Statistical signiﬁcance was determined by one-way analysis of
variance with Tukey post-comparison tests using a conﬁdence interval of 95%.
In vivo data were analysed by two-way analysis of variance with Bonferroni
post-test using a conﬁdence interval of 95%.
Data availability. The data that support the ﬁndings in this study are available in
the University of Cambridge data repository and are available with the doi
10.17863/CAM.778 (http://dx.doi.org/10.17863/CAM.778).
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